


Dr. Joel Cherlow, MD
Dr. Joel Cherlow, MD is a radiation oncologist in Laguna Hills, CA and has over 45 years of experience in the medical field. He graduated from UNIVERSITY OF CALIFORNIA AT LOS ANGELES / CENTER FOR HEALTH SCIENCES in 1979. He is affiliated with medical facilities MemorialCare Saddleback Medical Center and MemorialCare Miller Children's & Women's Hospital Long Beach.
Practice
24302 Paseo de Valencia Laguna Hills, CA 92653Make an Appointment
Hospital Highlight
Dr. Cherlow is affiliated with MemorialCare Saddleback Medical Center Laguna Hills, a highly rated hospital.
At a Glance
- Area of Expertise
- Friendly Staff
- Practices at Top Hospital
- Hospital Satisfaction

Save money with free prescription discounts
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Cherlow's Reviews
Likelihood to recommend Dr. Cherlow
3.4
5 Star | 60% | 60% |
4 Star | 0% | 0% |
3 Star | 0% | 0% |
2 Star | 0% | 0% |
1 Star | 40% | 40% |
Leave a review
How was your experience with Dr. Cherlow?Overall Patient Satisfaction
Likelihood of recommending Dr. Cherlow to family and friends is 3.4 out of 5
About Me
biography
Dr. Joel Cherlow, MD is a radiation oncologist in Laguna Hills, CA and has over 45 years of experience in the medical field. He graduated from UNIVERSITY OF CALIFORNIA AT LOS ANGELES / CENTER FOR HEALTH SCIENCES in 1979. He is affiliated with medical...read moreRadiation Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of California At Los Angeles / Center For Health Sciences
Medical School, 1979
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkIntrathecal methotrexate is sufficient central nervous system (CNS) prophylaxis for high risk patients with acute lymphoblastic leukemia (ALL) showing a rapid early response (RER) to BFM induction chemotherapy
Treatment of High Grade Spinal Cord Astrocytoma of Childhood with "8-in-1" Chemotherapy and Radiotherapy: A Pilot Study of CCG-945
Radiotherapy to extra-abdominal bulk disease and/or for central nervous system prophylaxis with intensive chemotherapy of acute lymphoblastic leukemia and lymphomatous presenting features
Radiation treatments or surgery in 33 cases of juvenile angiofibroma of the nasopharynx
Treatment of Patients with Acute Lymphoblastic Leukemia with Bulky Extramedullary Disease and T-Cell Phenotype or Other Poor Prognostic Features: Randomized Controlled Trial from the Children's Cancer Group
Children with acute lymphoblastic leukemia with lymphomatous features (ALL-LF) and normal marrow chromosomes have a better outcome than patients with abnormal chromosomes 9:219
Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy
High Dose Rate (HDR) Brachytherapy for Treatment of Primary Head and Neck Cancer.
Acute lymphoblastic leukemia (ALL) with lymphomatous features at diagnosis in children
Brachytherapy For Primary And Recurrent Nasopharyngeal Carcinoma: 20 Years Experience At Long Beach Memorial
The role of radiation therapy in the management of acute lymphoblastic leukemia with lymphomatous presentation (ALLILP)
Low-stage medulloblastoma: final analysis of trial comparing standard-dose reduced-dose neuraxis irradiation
Cranio-spinal radiation for CNS leukemia at presentation -- how high does the spinal dose need to be?
Predictive value of early response in intermediate risk acute lymphoblastic leukemia in children, Children's Cancer Group (CCG) 1891
Children's Cancer Group (CCG) study 1882: Augmented BFM (A-BFM) for treatment of children and young adults with high risk acute lymphoblastic leukemia (ALL) showing slow early response (SER)
Treatment of acute lymphoblastic leukemia with lymphomatous presenting features
"INDIRA" Trial: De Novo Low Dose Rate lntracoronary Irradiation After Angioplasty and Stent Placement for Prevention of Restenosis.
Early marrow response is a powerful predictor of outcome in acute lymphoblastic leukemia patients with unfavorable presenting features
Effective treatment of unresectable or metastatic hepatoblastoma with Cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Children's Cancer Study Group
Laser-induced hemostasis in the canine stomach
Cytoreduction and Prognosis in Acute Lymphoblastic Leukemia -- The Importance of Early Marrow Response: Report from the Children's Cancer Group
Response of Children With High-Risk Acute Lymphoblastic Leukemia Treated With and Without Cranial Irradiation: A Report from the Children's Cancer Group
Randomized Phase Ill Trial in Childhood High-Grade Astrocytoma Comparing Vincristine, Lomustine, and Prednisone With the Eight-Drugs-in-1-Day Regimen
Augmented Post-Induction Therapy for Children with High-Risk Acute Lymphoblastic Leukemia and a Slow Response to Initial Therapy
Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix
Temporary Implant in the Management of Carcinoma of the Prostate
Endocurietherapy in pediatric oncology
Results of a Prospective Randomized Trial Comparing Standard Dose Neuraxis Irradiation (3,600 cGy/20) with Reduced Neuraxis Irradiation (2,340 cGy/13) in Patients with Low-Stage Medulloblastoma: A Combined Children's Cancer Group-Pediatric Oncology Group Study
Early Testicular Biopsy in Males with Acute Lymphoblastic Leukemia: Lack of Impact on Subsequent Event-Free Survival
Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: A report from the Children's Cancer Group
Endoscopic argon-ion laser phototherapy of bleeding gastric lesions
The effect of pre-irradiation chemotherapy on the delivery of radiation therapy for medulloblastoma and supratentorial PNET. Results of the CCG #921 randomized protocol
Cranio-spinal Irradiation for Acute Lymphoblastic Leukemia with CNS Disease at Diagnosis - A Report from the Children's Cancer Group
Treatment of High Grade Spinal Cord Astrocytoma of Childhood with "8-in-1" Chemotherapy and Radiotherapy: A Pilot Study of CCG-945
Results of a Multi-Institutional Benchmark Test for Cranial CT/MR Image Registration.
Gastric hemostasis by laser phototherapy in man
Outcome of a phase Ill trial in childhood high-grade astrocytoma comparing vincristine, CCNU and prednisone with the 'in-drugs-in-1-day' regimen. A report of the Children's Cancer Group Trial CCG-945
High dose rate brachytherapy in the treatment of carcinoma of the prostate
Cranial radiation (CRT) improves event free survival (EFS) for high risk patients with acute lymphoblastic leukemia (ALL) showing a rapid response (RR) to BFM induction chemotherapy
Brain Stem Gliomas of Childhood: Outcome after Treatment with 7800 cGy of Hyperfractionated Radiotherapy, A Children's Cancer Group Phase 1/11 Trial
The Effects of Initial Central Nervous System (CNS) Status on the Outcome of Children with Acute Lymphoblastic Leukemia (ALL)." Proceeding of the AmericanSociety for Therapeutic Radiology and Oncology, 441 Annual Meeting.
Longitudinal Study of Cognitive, Motor, and Behavioral Functioning in Children Diagnosed with Acute Lymphoblastic Leukemia: A Report of Early Findings from the Children's Cancer Group". Acute Leukemias VI Prognostic Factors and Treatment Strategies, Buchner et al. (Eds)
Best Doctor in America Radiation Oncology (Woodward-White), 2003 - 200
Pediatric Oncology Physician of the Year, Long Beach Memorial Medical Center, 1998
Physician of the Quarter, Saddleback Memorial Medical Center, 2nd Quarter, 2001
Pediatric Oncology Physician of the Year, Long Beach Memorial Medical Center, 1993
Best Doctor in America, Pediatric Radiation Oncology (Woodward-White), 1998 - 199
Focus on Breast Cancer
Locations
Practice
Practice
Affiliated Hospitals
- Recipient of 25
hospital awardsAmerica's 250 Best Hospitals Award™ (2025, 2024, 2023)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all awardsPatient Safety Excellence Award™ (2025, 2024)
Top in the nation for providing excellence in patient safety by preventing infections, medical errors, and other preventable complications
View all patient feedbackHow patients felt about the care they received at this hospital.
86%Patients said they were given information about recovering at home2% higher than the national average
77%Patients said that doctors always listened to them and explained things well1% higher than the national average
Compare Providers
Providers shown based on Dr. Cherlow's location and specialty. Show more Radiation Oncologists.
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.